Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1989 5
1990 14
1991 16
1992 9
1993 10
1994 14
1995 12
1996 19
1997 36
1998 56
1999 61
2000 36
2001 47
2002 50
2003 95
2004 130
2005 125
2006 170
2007 174
2008 185
2009 163
2010 148
2011 188
2012 179
2013 182
2014 163
2015 145
2016 128
2017 90
2018 79
2019 73
2020 47
2021 47
2022 37
2023 29
2024 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,723 results

Results by year

Filters applied: . Clear all
Page 1
Adefovir for lamivudine-resistant hepatitis B.
Roediger R, Smyth EK, Dieterich D. Roediger R, et al. Antivir Ther. 2022 Apr;27(2):13596535211067605. doi: 10.1177/13596535211067605. Antivir Ther. 2022. PMID: 35499182 Free article. Review.
Adefovir, a nucleotide analog developed by John Martin, was a major breakthrough in the treatment of chronic Hepatitis B. ...Adefovir was found to be effective in suppressing viral replication and in resolving the hepatic inflammation associated with hepatitis B wit
Adefovir, a nucleotide analog developed by John Martin, was a major breakthrough in the treatment of chronic Hepatitis B. ...Adefo
Adefovir-induced osteomalacia and hypophosphatemia.
López Medina JA, Simón Frapolli VJ, Tinahones Madueño FJ. López Medina JA, et al. Med Clin (Barc). 2022 Mar 11;158(5):245. doi: 10.1016/j.medcli.2021.05.019. Epub 2021 Jul 10. Med Clin (Barc). 2022. PMID: 34256937 English, Spanish. No abstract available.
Adefovir dipivoxil in the treatment of chronic hepatitis B virus infection.
Hadziyannis SJ, Papatheodoridis GV. Hadziyannis SJ, et al. Expert Rev Anti Infect Ther. 2004 Aug;2(4):475-83. doi: 10.1586/14787210.2.4.475. Expert Rev Anti Infect Ther. 2004. PMID: 15482214 Review.
Adefovir dipivoxil (Hepsera, Gilead Sciences) is a prodrug of adefovir, with potent antiviral activity against hepatitis B virus. Adefovir dipivoxil therapy, 10 mg daily for 48 weeks, is effective in hepatitis B e antigen-positive and -negative chronic hepati
Adefovir dipivoxil (Hepsera, Gilead Sciences) is a prodrug of adefovir, with potent antiviral activity against hepatitis B vir
Evaluation of Ion-pair Formation of Adefovir to Improve Permeation across Artificial and Biological Membranes.
Darsazan B, Shafaati A, Zarghi A, Mortazavi SA. Darsazan B, et al. J Pharm Pharm Sci. 2018;21(1):160-170. doi: 10.18433/jpps29394. J Pharm Pharm Sci. 2018. PMID: 29789103 Free article. Review.
The apparent permeability of adefovir-CPC (counter-ion) was 1.3-fold greater than that of adefovir dipivoxil permeability in a biologic membrane (everted gut sac). CONCLUSION: These results suggest that the adefovir-CPC ion-paired system has potential for imp …
The apparent permeability of adefovir-CPC (counter-ion) was 1.3-fold greater than that of adefovir dipivoxil permeability in a …
Adefovir-induced Fanconi syndrome associated with osteomalacia.
Park S, Kim WI, Cho DH, Kim YJ, Kim HS, Kim JH, Cha SK, Park KS, Lee JH, Lee SM, Lee EY. Park S, et al. Clin Mol Hepatol. 2018 Sep;24(3):339-344. doi: 10.3350/cmh.2017.0009. Epub 2017 Sep 1. Clin Mol Hepatol. 2018. PMID: 28859264 Free article.
Here we report the case of a 36-year-old woman who presented with pain in multiple bones and proteinuria. She had a 7-year history of taking adefovir at 10 mg/day for chronic hepatitis B. Three years previously she had received surgery for a nontraumatic right femur neck f …
Here we report the case of a 36-year-old woman who presented with pain in multiple bones and proteinuria. She had a 7-year history of taking …
Comparison of the efficacy of tenofovir and adefovir in the treatment of chronic hepatitis B: a systematic review.
Zhao SS, Tang LH, Dai XH, Wang W, Zhou RR, Chen LZ, Fan XG. Zhao SS, et al. Virol J. 2011 Mar 9;8:111. doi: 10.1186/1743-422X-8-111. Virol J. 2011. PMID: 21388525 Free PMC article. Review.
Currently, several drugs, such as tenofovir and adefovir, are recommended for treatment of patients with chronic hepatitis B. tenofovir is a nucleoside analog with selective activity against hepatitis b virus and has been shown to be more potent in vitro than adefovir
Currently, several drugs, such as tenofovir and adefovir, are recommended for treatment of patients with chronic hepatitis B. tenofov …
Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.
Cundy KC. Cundy KC. Clin Pharmacokinet. 1999 Feb;36(2):127-43. doi: 10.2165/00003088-199936020-00004. Clin Pharmacokinet. 1999. PMID: 10092959 Review.
Cidofovir and adefovir are members of a new class of antiviral compounds. They are acyclic phosphonate analogues of deoxynucleoside monophosphates. ...The low oral bioavailability of adefovir has led to the development of an oral prodrug, adefovir dipivoxil, …
Cidofovir and adefovir are members of a new class of antiviral compounds. They are acyclic phosphonate analogues of deoxynucleoside m …
2,723 results